New Releases from NCBI BookshelfZolbetuximab for Injection (Vyloy): Therapeutic area: Gastric or gastroesophageal junction adenocarcinoma: Reimbursement Review [Internet].Zolbetuximab for Injection (Vyloy): Therapeutic area: Gastric or gastroesophageal junction adenocarcinoma: Reimbursement Review [Internet].
Post Content
